|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Fenofibrate]] |
| {{Fenofibrate}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Contraindications==
| |
| Antara is contraindicated in:
| |
| | |
| *patients with severe [[renal impairment]], including those receiving dialysis [see Clinical Pharmacology (12.3) ].
| |
| *patients with active liver disease, including those with primary biliary cirrhosis and unexplained persistent liver function abnormalities [see Warnings and Precautions (5.3) ].
| |
| *patients with pre-existing gallbladder disease [see Warnings and Precautions (5.5) ].
| |
| *nursing mothers [see Use in Specific Populations (8.3) ].
| |
| *patients with known [[hypersensitivity ]]to [[fenofibric acid]] or fenofibrate [see Warnings and Precautions (5.9) ].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TRIGLIDE (FENOFIBRATE) TABLET [SHIONOGI INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=94a4a99b-24df-4e81-b409-5325d36647d2#nlm34067-9 | publisher = | date = | accessdate = 12 February 2014 }}</ref>
| |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| {{Lipid modifying agents}}
| |
| {{Antigout preparations}}
| |
| | |
| [[Category:Fibrates]] | |
| [[Category:Prodrugs]]
| |
| [[Category:Organochlorides]]
| |
| [[Category:Benzophenones]]
| |
| [[Category:Phenol ethers]]
| |
| [[Category:Carboxylate esters]]
| |